Browsing Tag
Hikma
17 posts
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreement with…
Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region
London, England — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreements with Celltrion…
Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets
Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with Adalvo…
Hikma’s diversified business delivers resilient H1 performance
London, United Kingdom — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its interim…
Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with…
Siggi Olafsson to step down as Chief Executive
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma) today announces that Siggi Olafsson has resigned as Chief Executive…
Hikma and Almirall to market FinjuveTM in the MENA
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has entered into an exclusive licensing agreement…